VBI Vaccines Inc VBIV

VBI Vaccines Inc

Biotechnology

Healthcare

VBIV

8.62 M shares

NASDAQ US

traded

14 Aug 2023

listed

yes

open

1.23

52 week high

4.65

high

1.35

52 week low

1.32

low

1.18

growth

-57.81 %

previous Close

1.32

P/E ratio

-0

market cap

28.82 M

div yield

0

usd

Mar 2023

qoq

revenue

485 K

65.53 %

net incoming

-37.42 M

-90.59 %

eps

-3.22 %

-3.00 %

eps surprise

-157.60 %

net profit margin

-7715.88 %

-1014.00 %

operating incoming

-19.51 M

9.00 %

net change in cash

-22.24 M

-6.29 %

cash on hand

40.39 M

-35.51 %

cost of revenue

3.56 M

6.94 %